104 related articles for article (PubMed ID: 17283123)
1. Demethylation-linked activation of urokinase plasminogen activator is involved in progression of prostate cancer.
Pulukuri SM; Estes N; Patel J; Rao JS
Cancer Res; 2007 Feb; 67(3):930-9. PubMed ID: 17283123
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA directed reversal of urokinase plasminogen activator demethylation inhibits prostate tumor growth and metastasis.
Pulukuri SM; Rao JS
Cancer Res; 2007 Jul; 67(14):6637-46. PubMed ID: 17638874
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide promoter DNA methylation profiling of hepatocellular carcinomas arising either spontaneously or due to chronic exposure to Ginkgo biloba extract (GBE) in B6C3F1/N mice.
Kovi RC; Bhusari S; Mav D; Shah RR; Ton TV; Hoenerhoff MJ; Sills RC; Pandiri AR
Arch Toxicol; 2019 Aug; 93(8):2219-2235. PubMed ID: 31278416
[TBL] [Abstract][Full Text] [Related]
4. The Methylation Status of the Epigenome: Its Emerging Role in the Regulation of Tumor Angiogenesis and Tumor Growth, and Potential for Drug Targeting.
Pirola L; Ciesielski O; Balcerczyk A
Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30103412
[TBL] [Abstract][Full Text] [Related]
5. Retraction: Small Interfering RNA-Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis.
Cancer Res; 2018 Jun; 78(12):3398. PubMed ID: 29907683
[No Abstract] [Full Text] [Related]
6. Retraction: Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer.
Cancer Res; 2018 Jun; 78(12):3397. PubMed ID: 29907682
[No Abstract] [Full Text] [Related]
7. Methyl donor S-adenosylmethionine (SAM) supplementation attenuates breast cancer growth, invasion, and metastasis
Mahmood N; Cheishvili D; Arakelian A; Tanvir I; Khan HA; Pépin AS; Szyf M; Rabbani SA
Oncotarget; 2018 Jan; 9(4):5169-5183. PubMed ID: 29435170
[TBL] [Abstract][Full Text] [Related]
8. Hypomethylation coordinates antagonistically with hypermethylation in cancer development: a case study of leukemia.
Kushwaha G; Dozmorov M; Wren JD; Qiu J; Shi H; Xu D
Hum Genomics; 2016 Jul; 10 Suppl 2(Suppl 2):18. PubMed ID: 27461342
[TBL] [Abstract][Full Text] [Related]
9. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM
Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774
[TBL] [Abstract][Full Text] [Related]
10. DNA Methylation and Flavonoids in Genitourinary Cancers.
Mukherjee N; Kumar AP; Ghosh R
Curr Pharmacol Rep; 2015 Apr; 1(2):112-120. PubMed ID: 26005633
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation regulates expression of VEGF-C, and S-adenosylmethionine is effective for VEGF-C methylation and for inhibiting cancer growth.
Da MX; Zhang YB; Yao JB; Duan YX
Braz J Med Biol Res; 2014 Dec; 47(12):1021-8. PubMed ID: 25387667
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of Amyloid-β Peptide Clearance: Potential Therapeutic Targets for Alzheimer's Disease.
Yoon SS; Jo SA
Biomol Ther (Seoul); 2012 May; 20(3):245-55. PubMed ID: 24130920
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-Beta and urokinase-type plasminogen activator: dangerous partners in tumorigenesis-implications in skin cancer.
Santibanez JF
ISRN Dermatol; 2013; 2013():597927. PubMed ID: 23984088
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic markers of urothelial cancer based on DNA methylation analysis.
Chihara Y; Kanai Y; Fujimoto H; Sugano K; Kawashima K; Liang G; Jones PA; Fujimoto K; Kuniyasu H; Hirao Y
BMC Cancer; 2013 Jun; 13():275. PubMed ID: 23735005
[TBL] [Abstract][Full Text] [Related]
15. An integrated approach to uncover driver genes in breast cancer methylation genomes.
Shen X; Li S; Zhang L; Li H; Hong G; Zhou X; Zheng T; Zhang W; Hao C; Shi T; Liu C; Guo Z
PLoS One; 2013; 8(4):e61214. PubMed ID: 23579546
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced hypomethylation triggers urokinase plasminogen activator transcription in meningioma cells.
Velpula KK; Gogineni VR; Nalla AK; Dinh DH; Rao JS
Neoplasia; 2013 Feb; 15(2):192-203. PubMed ID: 23441133
[TBL] [Abstract][Full Text] [Related]
17. Suppression of LFA-1 expression by spermine is associated with enhanced methylation of ITGAL, the LFA-1 promoter area.
Kano Y; Soda K; Konishi F
PLoS One; 2013; 8(2):e56056. PubMed ID: 23418509
[TBL] [Abstract][Full Text] [Related]
18. Distinct functional patterns of gene promoter hypomethylation and hypermethylation in cancer genomes.
Shen X; He Z; Li H; Yao C; Zhang Y; He L; Li S; Huang J; Guo Z
PLoS One; 2012; 7(9):e44822. PubMed ID: 22970311
[TBL] [Abstract][Full Text] [Related]
19. Molecular marks for epigenetic identification of developmental and cancer stem cells.
Patra SK; Deb M; Patra A
Clin Epigenetics; 2011 Apr; 2(1):27-53. PubMed ID: 22704268
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
